As neurological disorders contribute nearly 10% to India’s overall disease burden, innovation in advanced neurotechnology is gaining momentum. Gurugram-based Medanta – The Medicity is positioning its Deep Brain Stimulation (DBS) programme, widely known as ‘Brain Pacemaker’ surgery, at the forefront of technology-led neurological care.
Recognised as an international destination for DBS and ranked Best Private Hospital in India by Newsweek for six consecutive years, Medanta’s programme has evolved into a centre of excellence offering relief to patients with advanced-stage Parkinson’s disease, dystonia, refractory epilepsy (adult onset), essential tremor and advanced obsessive-compulsive disorder (OCD), particularly when conventional therapies fail.
The initiative is led by Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram, who has performed over 300 DBS procedures in the past decade-and-a-half with consistently high success rates. DBS involves implanting electrodes in targeted brain regions to regulate abnormal signals and restore motor function. What differentiates Medanta’s approach is its integration of advanced imaging for precise brain targeting, directional leads for multi-dimensional neuromodulation, real-time brain-sensing biomarker feedback, AI-guided precision targeting and remote programming capabilities—allowing personalised, data-driven and symptom-responsive treatment even after surgery.